Multichem® ID-COVID19Neg

Multichem® ID-COVID19Neg is an unassayed negative third-party quality control for Immunoglobulin G (IgG) antibodies to SARS-CoV-2.
This quality control is available with access to our interlaboratory Peer program, IAMQC®.

Multichem ID-COVID19Neg is an unassayed negative control with no platform claims in the USA.

Multichem ID-B in instrument rack

Product Description

The Multichem ID-COVID19Neg (unassayed) is a negative third-party quality control for Immunoglobulin G (IgG) antibodies to SARS-CoV-2. The kit is delivered in 4 x 4mL vials. The product is suitable for use on all major platforms, including amongst others, Abbott, Roche and Siemens.

All Multichem ID-COVID19 quality controls are supported by our interlaboratory Peer program, IAMQC®.

INFORMATION FOR USA ONLY:
This product is not intended for use in donor screening
testing. This is an unassayed product, with no platform claims in
the USA.

Show

Benefits

Assess the precision of COVID-19 assays

Satisfies regulatory guidelines for use of independent controls

Long shelf life extends lot availability

Track product performance with IAMQC

Features

36 month closed vial stability at 2°C to 8°C

30 day open vial stability at 2°C to 8°C

Ready-to-use liquid stable

Third party independent quality control

Analyte List

Negative for Immunoglobulin G (IgG) antibodies to SARS-CoV-2

Ordering

Name

Description

Kit

Part Code

Multichem ID-COVID19Neg

Unassayed Negative Control in Vials

4 x 4mL

CVN200N

Name

Multichem ID-COVID19Neg

Description

Unassayed Negative Control in Vials

Kit

4 x 4mL

Part Code

CVN200N

Order Multichem ID-COVID19Neg Today

IAMQC Peer

IAMQC interlaboratory peer program for Multichem ID-COVID19 quality controls

IAMQC Peer

IAMQC Peer enables the laboratory to monitor its own reliability and precision by real-time comparison of its QC test data with other laboratories across the globe.

Learn More

Electronic Instructions For Use (eIFU)

Multichem ID-B Instructions for Use

Electronic Instructions For Use (eIFU)

Navigate to our eIFU page to easily access an electronic version the product instructions for use.

Go To eIFU page

Find a product by analyte, instrument, partcode or name

Why Technopath

Technopath was the first company in the world to develop truly consolidated third party quality controls for hospital laboratories.

Through the benefits of test consolidated QC, Technopath’s Multichem® customers have increased their laboratory efficiencies and reduced the cost of their quality control program.

Discover More

Our Clients

The main driver for change was a mandate to consolidate and improve workflow efficiencies. Reduced physical cost, coupled with a reduction in staff time, proved significant.

Blackrock Clinic Dublin - Eoin O’Rourke, Head of Pathology, Blackrock Clinic Ltd., Blackrock, Co. Dublin, Ireland

In 2017, Technopath signed a global agreement with Beckman Coulter Diagnostics.

"Technopath’s highly efficient QC solution will help Beckman Coulter customers address the strong and growing demand for multi-constituent quality control products, and meets the requirements of lab accreditation."

John Blackwood - Senior Vice President of Products and Services at Beckman Coulter.

Sign up to our newsletter for the latest updates

Be one of the first to receive news from Technopath Clinical Diagnostics.